The expression of MAPK10 was associated with the DFI (disease-free interval, P = 0.033), PFI (progression-free interval, P = 0.013), DSS (disease-specific survival, P = 0.0068), and OS (overall survival, P = 0.017) in GC (Fig. 5d–g), suggesting that MAPK10 plays a key role as an oncogene in GC. The gene discussed is MAPK10; the disease is gastric cancer.